Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • J. Hobart - (Author)
  • T. Ziemssen - , Department of Neurology (Author)
  • P. Feys - (Author)
  • M. Linnebank - (Author)
  • A.D. Goodman - (Author)
  • R. Farrell - (Author)
  • R. Hupperts - (Author)
  • A.R. Blight - (Author)
  • V. Englishby - (Author)
  • M. McNeill - (Author)
  • I. Chang - (Author)
  • G. Lima - (Author)
  • J. Elkins - (Author)

Details

Original languageEnglish
JournalCNS drugs
Publication statusPublished - 2019
Peer-reviewedYes

External IDs

Scopus 85058243556

Keywords